These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1792659)

  • 1. [Round table on the methodology of clinical evaluation of prostaglandins in the treatment of arteriopathies].
    Fiessinger JN; Boccalon H; Guilmot JL; Serise JM
    Therapie; 1991; 46(3):247-51. PubMed ID: 1792659
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN; Potortì F; Urbano O; Perroni GB
    Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
    D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
    Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of critical leg ischaemia and mode of action of prostaglandins.
    Bertele V; Cerletti C; de Gaetano G
    Agents Actions Suppl; 1992; 37():18-26. PubMed ID: 1632292
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of prostaglandins in the treatment of gastric and duodenal ulcers].
    Florent C; Desaint B
    Gastroenterol Clin Biol; 1988 Oct; 12(10):743-54. PubMed ID: 3065124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].
    Szczeklik A; Głusko P; Gryglewski R; Szczeklik J; Kostka-Trabka E; Grodzińska L; Nizanowski R; Dembińska-Kieć A; Skawiński S; Bieroń K; Billewicz O; Telesz E
    Przegl Lek; 1980; 37(9):659-62. PubMed ID: 6106960
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V; Gabrielli F
    Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effect of polopirin S on platelet adhesiveness in chronic peripheral circulatory failure in arteriosclerosis].
    Obara A; Płachta H; Maruszyński M; Bober S; Zero E
    Wiad Lek; 1988 Nov; 41(21):1427-31. PubMed ID: 3074580
    [No Abstract]   [Full Text] [Related]  

  • 9. [Double blind clinical experiences with L.S. 121 (praxilene) in patients with chronic ischemic peripheral syndromes].
    Bianchi G
    Minerva Chir; 1974 Aug; 29(15-16):885-90. PubMed ID: 4607675
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of hemorrheological drugs in microcirculatory ischemia].
    Avellone G; Di Garbo V; Panno AV; Longo B; Accardo MA; Strano A
    Clin Ter; 1987 Jul; 122(2):121-7. PubMed ID: 2973901
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ketanserin in ischemic disease of the lower extremities. Results of a double-blind cross-over study].
    Broulíková A; Linhart J
    Cas Lek Cesk; 1987 Sep; 126(35-36):1094-6. PubMed ID: 3311372
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of PGs in fertility control.
    Sparks RM; Lee CM
    Popul Rep G; 1973 Apr; (1):G1-15. PubMed ID: 4615001
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of peripheral arterial disease with prostacyclin. I. Effect of prostacyclin on the healing of ischemic ulcers of the lower extremities].
    Nizankowski R
    Kardiol Pol; 1986; 29(3):209-17. PubMed ID: 3534429
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic effect of ticlopidine for ischemic leg ulcers.
    Katsumura T
    Agents Actions Suppl; 1984; 15():167-72. PubMed ID: 6385645
    [No Abstract]   [Full Text] [Related]  

  • 15. [Eicosanoic acids and arteriopathies of the legs].
    Jouve R
    Cardiologia; 1986 Jun; 31(6):399-401. PubMed ID: 3545470
    [No Abstract]   [Full Text] [Related]  

  • 16. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical observations with intravenous prostaglandin E1 in peripheral vascular disease.
    Feldman SM; Alpert J; Dick LS; Brief DK; Goldenkranz R; Brener BJ; Parsonnet V
    J Med Soc N J; 1982 Dec; 79(13):985-7. PubMed ID: 6961223
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemostatic effects of iloprost in patients with lower limb ischemia.
    Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Soraci S; Bartolone S; Bagnato L; Barbera N
    Panminerva Med; 1997 Sep; 39(3):202-4. PubMed ID: 9360422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulated angiogenesis: a new trend in the treatment of ischemic conditions].
    Davydenko VV; Machs VM
    Vestn Khir Im I I Grek; 2000; 159(1):117-20. PubMed ID: 10890120
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.